212 related articles for article (PubMed ID: 9563900)
1. Interleukin 6 differentially potentiates the antitumor effects of taxol and vinblastine in U266 human myeloma cells.
Aoyama M; MacIsaac D; Bukowski RM; Ganapathi MK
Clin Cancer Res; 1998 Apr; 4(4):1039-45. PubMed ID: 9563900
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of taxol on two human cancer cell lines.
Banerjee S; Fallis AG; Brown DL
Oncol Res; 1997; 9(5):237-48. PubMed ID: 9306431
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells.
Gorodetsky R; Levdansky L; Ringel I; Vexler A
Radiat Res; 1998 Sep; 150(3):283-91. PubMed ID: 9728657
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Taxol-induced cell death are concentration dependent.
Torres K; Horwitz SB
Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870
[TBL] [Abstract][Full Text] [Related]
5. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines.
Speicher LA; Barone L; Tew KD
Cancer Res; 1992 Aug; 52(16):4433-40. PubMed ID: 1353706
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells.
Shtil AA; Mandlekar S; Yu R; Walter RJ; Hagen K; Tan TH; Roninson IB; Kong AN
Oncogene; 1999 Jan; 18(2):377-84. PubMed ID: 9927194
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells.
Ling YH; Yang Y; Tornos C; Singh B; Perez-Soler R
Cancer Res; 1998 Aug; 58(16):3633-40. PubMed ID: 9721872
[TBL] [Abstract][Full Text] [Related]
8. Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein.
Ponnathpur V; Ibrado AM; Reed JC; Ray S; Huang Y; Self S; Bullock G; Nawabi A; Bhalla K
Clin Cancer Res; 1995 Nov; 1(11):1399-406. PubMed ID: 9815937
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of cholinergic receptor-mediated 45Ca++ uptake and catecholamine secretion from adrenal chromaffin cells by taxol and vinblastine.
McKay DB; Schneider AS
J Pharmacol Exp Ther; 1984 Oct; 231(1):102-8. PubMed ID: 6149300
[TBL] [Abstract][Full Text] [Related]
10. Difluoromethylornithine antagonizes taxol cytotoxicity in MCF-7 human breast cancer cells.
Das B; Rao AR; Madhubala R
Oncol Res; 1997; 9(11-12):565-72. PubMed ID: 9563003
[TBL] [Abstract][Full Text] [Related]
11. Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1.
Fan M; Du L; Stone AA; Gilbert KM; Chambers TC
Cancer Res; 2000 Nov; 60(22):6403-7. PubMed ID: 11103805
[TBL] [Abstract][Full Text] [Related]
12. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
Stone AA; Chambers TC
Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
[TBL] [Abstract][Full Text] [Related]
13. Control mechanisms of tubulin gene expression in Trypanosoma cruzi.
da Silva RA; Bartholomeu DC; Teixeira SM
Int J Parasitol; 2006 Jan; 36(1):87-96. PubMed ID: 16233898
[TBL] [Abstract][Full Text] [Related]
14. Effect of drugs affecting microtubular assembly on microtubules, phospholipid synthesis and physiological indices (signalling, growth, motility and phagocytosis) in Tetrahymena pyriformis.
Kovács P; Csaba G
Cell Biochem Funct; 2006; 24(5):419-29. PubMed ID: 15912561
[TBL] [Abstract][Full Text] [Related]
15. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
16. The interaction of taxol and vinblastine with radiation induction of p53 and p21 WAF1/CIP1.
Tishler RB; Lamppu DM
Br J Cancer Suppl; 1996 Jul; 27():S82-5. PubMed ID: 8763853
[TBL] [Abstract][Full Text] [Related]
17. Taxol induces concomitant hyperphosphorylation and reorganization of vimentin intermediate filaments in 9L rat brain tumor cells.
Chu JJ; Chen KD; Lin YL; Fei CY; Chiang AS; Chiang CD; Lai YK
J Cell Biochem; 1998 Mar; 68(4):472-83. PubMed ID: 9493910
[TBL] [Abstract][Full Text] [Related]
18. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
Bollag DM; McQueney PA; Zhu J; Hensens O; Koupal L; Liesch J; Goetz M; Lazarides E; Woods CM
Cancer Res; 1995 Jun; 55(11):2325-33. PubMed ID: 7757983
[TBL] [Abstract][Full Text] [Related]
19. The mode of action of taxol: apoptosis at low concentration and necrosis at high concentration.
Yeung TK; Germond C; Chen X; Wang Z
Biochem Biophys Res Commun; 1999 Sep; 263(2):398-404. PubMed ID: 10491305
[TBL] [Abstract][Full Text] [Related]
20. Taxol reduces cytosolic E-cadherin and beta-catenin levels in nasopharyngeal carcinoma cell line TW-039: cross-talk between the microtubule- and actin-based cytoskeletons.
Lou PJ; Chen WP; Lin CT; Chen HC; Wu JC
J Cell Biochem; 2000 Sep; 79(4):542-56. PubMed ID: 10996845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]